申请人:Pfizer Products Inc.
公开号:EP1273576A1
公开(公告)日:2003-01-08
The present invention relates to compounds of the formula
wherein m, R1, R3, R4, and R5 are defined as in the specification, to pharmaceutical compositions containing them and to their medicinal use. The compounds of the invention are useful in the treatment or alleviation of inflammation and other inflammation associated disorders, such as osteoarthritis, rheumatoid arthritis, colon cancer and Alzheimer's disease, in mammals (preferably humans, dogs, cats and livestock).
本发明涉及式如下的化合物
其中m、R1、R3、R4和R5的定义如说明书中所述,本发明涉及含有这些化合物的药物组合物及其药用用途。本发明的化合物可用于治疗或缓解哺乳动物(最好是人、狗、猫和家畜)的炎症和其他炎症相关疾病,如骨关节炎、类风湿性关节炎、结肠癌和阿尔茨海默病。